• Search History (Register)
  • MeSH Browser
Sort by Relevance
Search Results [535 Hits] Selected Records [0 Hits] [Clear]
Year Source Title
2027 Belgian Health Care Knowledge Centre (KCE) Review of new oncology indications for the use of positron emission tomography (PET-scans) (Study 2024-12)
2026 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [X-ray image of the lung: Can artificial intelligence support the analysis of X-ray images?]
2025 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Consumer health information on lung cancer screening using low-dose computed tomography]
2025 Norwegian Medical Products Agency (NOMA) [Photon-counting detector computed tomography]
2024 Ontario Health Single-exposure, dual-energy subtraction flat panel x-ray detectors: a health technology assessment
2024 Health Technology Wales (HTW) Low energy contact x-ray brachytherapy (CXB) for the treatment of early stage rectal cancer
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Assessment of lung cancer screening using low-dose computed tomography]
2024 HTA Region Stockholm [Comparing coronary computed tomography angiography (CCTA) to exercise electrocardiogram for suspected coronary artery disease: impact on patient outcomes]
2024 Scottish Health Technologies Group (SHTG) FDG PET dementia imaging - SHTG Recommendation
2024 NIHR Health and Social Care Delivery Program Artificial intelligence software for analysing chest X-ray images to identify suspected lung cancer: an evidence synthesis early value assessment
2024 NIHR Health Technology Assessment programme MRI software and cognitive fusion biopsies in people with suspected prostate cancer: a systematic review, network meta-analysis and cost-effectiveness analysis
2024 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Gozetotide (positron emission tomography, prostate cancer [mCRPC]) – Benefit assessment according to § 35a Social Code Book V]
2024 National Institute for Health and Care Excellence (NICE) MRI-guided focused ultrasound thalamotomy for treating moderate to severe tremor in Parkinson's. NICE interventional procedures guidance 796
2024 National Institute for Health and Care Excellence (NICE) MRI-guided focused ultrasound subthalamotomy for treating Parkinson's. NICE interventional procedures guidance 797
2023 NIHR Health Technology Assessment programme Impact of multiparametric MRI on staging and management of patients with suspected or confirmed ovarian cancer Short title: MR in Ovarian Cancer (MROC study)
2023 Austrian Institute for Health Technology Assessment (AIHTA) [Update PET/PET-CT evidence for need based planning in the area of oncology]
2023 Adelaide Health Technology Assessment (AHTA) Abdominal MRI for rare genetic conditions associated with increased risk of renal tumours
2023 Health Information and Quality Authority (HIQA) A slot-scanning, biplanar, digital X-ray imaging system for the evaluation and monitoring of orthopaedic conditions: evidence synthesis to support a generic justification decision
2023 Institute for Clinical Effectiveness and Health Policy (IECS) [Triple-phase computed tomography in patients with liver lesion]
2023 NIHR Health Technology Assessment programme Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation
2023 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Bimekizumab (non-radiographic axial spondyloarthritis) – Benefit assessment according to §35a Social Code Book V]
2023 Health Information and Quality Authority (HIQA) 18F-PSMA PET/CT in the staging of primary prostate cancer and the restaging of recurrent prostate cancer: evidence synthesis to support a generic justification decision
2023 Agency for Care Effectiveness (ACE) Ixekizumab and secukinumab for treating active non-radiographic axial spondyloarthritis
2023 National Institute for Health and Care Excellence (NICE) Upadacitinib for treating active non-radiographic axial spondyloarthritis. NICE technology appraisal guidance 861
2023 National Institute for Health and Care Excellence (NICE) MRI fusion biopsy systems for diagnosing prostate cancer. NICE diagnostics guidance 53
2023 National Institute for Health and Care Excellence (NICE) MRI-based technologies for assessing non-alcoholic fatty liver disease. NICE diagnostics guidance 50
2022 NIHR Health Technology Assessment programme Improving the prediction of metastatic disease in primary colorectal cancer: Prospective multicentre evaluation of a prognostic model of conventional predictive variables and novel variables derived from perfusion computed tomography (Perfusion CT)
2022 NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022 NIHR Health Technology Assessment programme Early computed tomography coronary angiography in adults presenting with suspected acute coronary syndrome: the RAPID-CTCA RCT
2022 NIHR Health Technology Assessment programme StereoTactic radiotherapy for wet Age-Related macular degeneration (STAR): A randomised, double-masked, sham- controlled, clinical trial comparing low-voltage X-ray irradiation with as needed ranibizumab, to as needed ranibizumab monotherapy
2022 NIHR Health Technology Assessment programme Dynamic contrast-enhanced CT compared with positron emission tomography CT to characterise solitary pulmonary nodules: the SPUtNIk diagnostic accuracy study and economic modelling
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [PSMA PET/CT staging in patients with prostate cancer biochemical recurrence]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Fluorodopa PET scanning in Parkinson’s disease]
2022 Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography angiography in vascular eye diseases]
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Stakeholders' perspectives of mobile x-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Residents' perspectives of mobile X-ray services in support of healthcare-in-place in residential aged care facilities: a qualitative study.
2022 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) The utilization and national variation of plain x-ray services by Australian residents of long-term care facilities
2021 German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Radiation exposure by medical X-ray applications]
2021 Scottish Medicines Consortium (SMC) Secukinumab for the treatment of active non-radiographic axial spondyloarthritis with objective signs of inflammation as indicated by elevated C-reactive protein (CRP) and/or magnetic resonance imaging (MRI) evidence in adults who have responded inadequately to nonsteroidal anti-inflammatory drugs (NSAIDs)
2021 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of single-photon emission computed tomography with [ 123I]ioflupane (DaTscan) in the diagnostic process for parkinsonian syndromes]
2021 Andalusian Health Technology Assessment Area (AETSA) [Clinical utility of optical coherence tomography angiography in exudative age-related macular degeneration management]
2021 Agency for Care Effectiveness (ACE) MRI-US fusion targeted biopsy for diagnosis of prostate cancer
2021 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Streamlining Medicare Benefits Schedule items for positron emission tomography (PET) project
2021 National Institute for Health and Care Excellence (NICE) Secukinumab for treating non-radiographic axial spondyloarthritis. NICE technology appraisal guidance 719
2020 NIHR Health Technology Assessment programme Positron emission tomography to image cerebral neuroinflammation in ischaemic stroke: a pilot study
2020 Austrian Institute for Health Technology Assessment (AIHTA) Update PET/PET-CT evidence for need based planning in the area of oncology
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Lung cancer screening using low-dose computed tomography]
2020 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Secukinumab (non-radiographic axial spondyloarthritis) - Benefit assessment according to §35a Social Code Book V]
2020 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) PSMA PET/CT imaging for informing treatment of patients with prostate cancer
2020 National Institute for Health and Care Excellence (NICE) MRI-guided laser interstitial thermal therapy for drug-resistant epilepsy. NICE interventional procedures guidance 671
2019 NIHR Health Technology Assessment programme MRI in the diagnosis of fetal developmental brain abnormalities: the MERIDIAN diagnostic accuracy study
2019 NIHR Health Technology Assessment programme Whole-body MRI compared with standard pathways for staging metastatic disease in lung and colorectal cancer: the Streamline diagnostic accuracy studies
2019 NIHR Health Technology Assessment programme Minimally invasive autopsy for fetuses and children based on a combination of post-mortem MRI and endoscopic autopsy examination; feasibility study
2019 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Diagnostic accuracy and clinical utility of PET/CT amyloid in mild cognitive impairment
2019 Andalusian Health Technology Assessment Area (AETSA) PET usefulness in non-oncological indications
2019 Health Technology Wales (HTW) Fluorine- or gallium- prostate-specific membrane antigen (PSMA) positron emission tomography (PET) radiotracers in the investigation of recurrent prostate cancer
2019 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: relevance of low-dose computed tomography lung cancer screening]
2019 Institut national d'excellence en sante et en services sociaux (INESSS) [Report: use of linear accelerators with on-board magnetic resonance imaging (MRI) for real-time MRI-guided radiation therapy treatments]
2019 Institute for Clinical Effectiveness and Health Policy (IECS) [PET-CT in patients with head and neck cancer diagnosis]
2019 Institute for Clinical Effectiveness and Health Policy (IECS) [Positron-emission tomography for breast cancer]
2019 Institute for Clinical Effectiveness and Health Policy (IECS) [Optical coherence tomography: usefulness in glaucoma, diabetic retinopathy and age-related macular degeneration]
2019 The Regional Health Technology Assessment Centre (HTA-centrum) Trabecular bone pattern assessment in dental radiographs for prediction of bone fracture risk
2019 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Idiopathic scoliosis: is video rasterstereography an adequate replacement for radiography in aftercare?]
2019 National Institute for Health and Care Excellence (NICE) Low-energy contact X-ray brachytherapy (the Papillon technique) for locally advanced rectal cancer. NICE interventional procedures guidance 659
2018 Medical Services Advisory Committee (MSAC) Computed tomography coronary angiogram - multi-slice computed tomography coronary angiography in the visualisation of coronary arteries
2018 NIHR Health Technology Assessment programme PET-PANC: multicentre prospective diagnostic accuracy and health economic analysis study of the impact of combined modality 18fluorine-2-fluoro-2-deoxy-d-glucose positron emission tomography with computed tomography scanning in the diagnosis and management of pancreatic cancer
2018 NIHR Health Technology Assessment programme MRI versus laparoscopy to diagnose the main causes of chronic pelvic pain in women: a test-accuracy study and economic evaluation
2018 NIHR Health Technology Assessment programme Multiparametric MRI to improve detection of prostate cancer compared with transrectal ultrasound-guided prostate biopsy alone: the PROMIS study
2018 NIHR Health Technology Assessment programme Combining optical coherence tomography with visual field data to rapidly detect disease progression in glaucoma: a diagnostic accuracy study
2018 NIHR Health Technology Assessment programme Low-dose computed tomography for lung cancer screening in high-risk populations: a systematic review and economic evaluation
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) Options to identify inappropriate use of MRI, Part 3
2018 Ludwig Boltzmann Institut fuer Health Technology Assessment (LBI-HTA) PET/PET-CT Evidence for need based planning in Germany and Austria
2018 Andalusian Health Technology Assessment Area (AETSA) 18F-FDG PET in early diagnosis of degenerative diseases of the central nervous system
2018 Norwegian Institute of Public Health (NIPH) Diagnostic accuracy, clinical effectiveness and budget impact of screening BRCA1/2 mutation carriers by MRI. A health technology assessment
2018 Institut national d'excellence en sante et en services sociaux (INESSS) [State of knowledge: strategies to optimize the appropriateness of MRI and CT requests - strategies and tools for optimal use]
2018 Institute for Clinical Effectiveness and Health Policy (IECS) [PET/CT scan for solitary pulmonary nodule and non-small cell lung cancer]
2018 Institute for Clinical Effectiveness and Health Policy (IECS) [Positron emission tomography (pet) for routine follow-up of selected neoplasms]
2018 Agency for Care Effectiveness (ACE) 18F-fluorodeoxyglucose positron emission tomography with computed tomography (FDG-PET-CT) for oncological indications
2018 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Amyloid PET in dementia of unclear aetiology]
2018 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Amyloid PET in dementia of unclear aetiology (Addendum to Commission E18-03)]
2018 National Institute for Health and Care Excellence (NICE) Golimumab for treating non-radiographic axial spondyloarthritis. NICE technology appraisal guidance 497
2018 National Institute for Health and Care Excellence (NICE) Transcranial MRI-guided focused ultrasound thalamotomy for neuropathic pain. NICE interventional procedures guidance 632
2018 National Institute for Health and Care Excellence (NICE) Unilateral MRI-guided focused ultrasound thalamotomy for treatment-resistant essential tremor. NICE interventional procedures guidance 617
2018 National Institute for Health and Care Excellence (NICE) Unilateral MRI-guided focused ultrasound thalamotomy for moderate to severe tremor in Parkinson's disease. NICE interventional procedures guidance 606
2017 NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017 NIHR Health Technology Assessment programme Is whole-colon investigation by colonoscopy, computerised tomography colonography or barium enema necessary for all patients with colorectal cancer symptoms, and for which patients would flexible sigmoidoscopy suffice? A retrospective cohort study
2017 NIHR Health Technology Assessment programme PET-NECK: a multicentre randomised Phase III non-inferiority trial comparing a positron emission tomography computerised tomography-guided watch-and-wait policy with planned neck dissection in the management of locally advanced (N2/N3) nodal metastases in patients with squamous cell head and neck cancer
2017 HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2017 HAYES, Inc. Positron emission tomography-computed tomography (PET-CT) for detection of primary site in neuroendocrine tumors of unknown origin
2017 Adelaide Health Technology Assessment (AHTA) Substitution of 68-Ga-DOTA-peptide PET/CT scanning in lieu of Octreotide for patients undergoing somatostatin receptor diagnostic imaging under MBS item 61369
2017 Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen (IQWiG) [Optical coherence tomography (OCT) for neovascular age-related macular degeneration as well as diabetic retinopathy with macular oedema]
2017 Australian Safety and Efficacy Register of New Interventional Procedures -Surgical (ASERNIP-S) Obstetric MRI
2016 NIHR Health Technology Assessment programme The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancer
2016 Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Low-dose computed tomography screening for lung cancer]
2016 NIHR Health Technology Assessment programme Tumour necrosis factor- inhibitors for ankylosing spondylitis and non-radiographic axial spondyloarthritis: a systematic review and economic evaluation
2016 HAYES, Inc. Positron Emission Tomography (PET) for Alzheimer disease
2016 HAYES, Inc. Combined positron emission tomography and magnetic resonance imaging for breast cancer staging
2016 Institute for Clinical Effectiveness and Health Policy (IECS) Positron emission tomography/magnetic resonance imaging (PET/MRI) in cancer
2016 HAYES, Inc. Optical Coherence Tomography (OCT) for plaque characterization and stent implantation
2016 HAYES, Inc. Noninvasive computed fractional flow reserve from computed tomography (FFRCT) for coronary artery disease